News Pharmacy regulator and royal college call on NICE to state propranolol is not recommended for anxiety The General Pharmaceutical Council, patient safety commissioner for England, Royal College of Pharmacy and College of Mental Health Pharmacy sent an open letter to NICE asking for it to update its guideline on use of 'highly toxic' medication.…Published: 7 October 2026
Feature Tase Oputu on the Royal College of Pharmacy’s first six months Six months after the launch of the Royal College of Pharmacy, its first president, Tase Oputu, sets out her priorities for the College and the profession.…Published: 7 October 2026
News Community pharmacy workforce figures fall despite overall growth in register Number of full-time equivalent pharmacists in England decreases by 14% since 2021, despite the General Pharmaceutical Council’s pharmacist register showing a growth of 2% since 2020, report shows.…Published: 7 October 2026
News Government accepts all 44 recommendations from regulation of AI in healthcare report The government said its acceptance commits the UK to develop a “world-leading agile approach to AI device regulation” that would support innovation while maintaining patient safety.…Published: 6 October 2026
News Nine in ten patients had ‘clinically relevant’ genetic variation in pharmacogenomics pilot The PROGRESS trial for pharmacogenomic guided prescribing in primary care enrolled more than 1,300 patients across 21 sites.…Published: 6 October 2026
Opinion Tase Oputu: ‘Be part of the conversation. Nobody’s opinions are invalid’ Tase Oputu, president of the Royal College of Pharmacy (RCPharm), talks about her experiences of leading the College and outlines RCPharm’s priorities over the next 12 months.…Published: 6 October 2026
News Patient safety alert issued as insulin treatment switching lags behind discontinuation deadline Clinicians have been told that patients must be switched from Levemir, used to treat diabetes, by the end of November 2026.…Published: 5 October 2026
News No clear increase in pregnancy risks after GLP-1 exposure, study suggests The study authors warned that the findings should not be read as proof that GLP-1 medicines are safe to use during pregnancy, with further research needed.…Published: 5 October 2026
Opinion Overcoming impostor syndrome and making a difference on the UKCPA neuroscience committee Impostor syndrome is a problem many people face while breaking into a sector — especially pharmacy — but how does one build confidence and succeed?…Published: 5 October 2026
Letter Core outcome set for pharmacist interventions in chronic kidney disease Pharmacists are suitably placed as healthcare professionals in multidisciplinary teams to manage people with chronic kidney disease (CKD). However, several systematic reviews of studies have demonstrated that there is a significant heterogeneity in outcomes and outcomes measures of pharmacist interv…Published: 5 October 2026
